Literature DB >> 7999098

Effect of acute diabetes on rat hepatic glucose-6-phosphatase activity and its messenger RNA level.

Z Liu1, E J Barrett, A C Dalkin, A D Zwart, J Y Chou.   

Abstract

Glucose-6-phosphatase catalyzes the final step of glucose production by liver and kidney. Though its strategic position has sparked interest in its regulation, difficulty with isolating a pure, stable enzyme has slowed progress. Virtually all previous work examining the physiologic regulation of this enzyme has relied on estimates of glucose-6-phosphatase activity in crude microsome preparations. The recent cloning of human and murine glucose-6-phosphatase cDNAs has now allowed study of its mRNA expression. We studied the effect of acute, streptozotocin-induced diabetes on hepatic microsomal glucose-6-phosphatase activity and mRNA expression in young (89 +/- 3 g), juvenile (304 +/- 4 g) and adult (512 +/- 10 g) rats. In control rats, mRNA expression and enzyme activity was similar among the three age groups. Streptozotocin-induced diabetes significantly increased the enzyme activities in both intact and triton-treated microsomes in all groups of rats (p < 0.001). Glucose-6-phosphatase mRNA expression was increased in the diabetic rats as well (p < 0.0001). Blood glucose concentrations correlated significantly with glucose-6-phosphatase mRNA level (p < 0.005) and both intact (p < 0.002) and triton-treated (p < 0.001) microsomal glucose-6-phosphatase activity. Both intact and triton-treated microsomal glucose-6-phosphatase activity correlated with mRNA level (p < 0.001, for each). We conclude that acute streptozotocin-diabetes increase expression of glucose-6-phosphatase mRNA and this contributes to the increased glucose-6-phosphatase activity seen with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7999098     DOI: 10.1006/bbrc.1994.2719

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Erythritol reduces small intestinal glucose absorption, increases muscle glucose uptake, improves glucose metabolic enzymes activities and increases expression of Glut-4 and IRS-1 in type 2 diabetic rats.

Authors:  Chika Ifeanyi Chukwuma; Ramgopal Mopuri; Savania Nagiah; Anil Amichund Chuturgoon; Md Shahidul Islam
Journal:  Eur J Nutr       Date:  2017-08-02       Impact factor: 5.614

2.  Liver glucose-6-phosphatase proteins in suckling and weaned grey seal pups: structural similarities to other mammals and relationship to nutrition, insulin signalling and metabolite levels.

Authors:  K A Bennett; M Hammill; S Currie
Journal:  J Comp Physiol B       Date:  2013-06-07       Impact factor: 2.200

3.  Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen.

Authors:  R M O'Doherty; P B Jensen; P Anderson; J G Jones; H K Berman; D Kearney; C B Newgard
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

4.  Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy.

Authors:  Wai Han Yiu; Young Mok Lee; Wen-Tao Peng; Chi-Jiunn Pan; Paul A Mead; Brian C Mansfield; Janice Y Chou
Journal:  Mol Ther       Date:  2010-04-13       Impact factor: 11.454

5.  In islet-specific glucose-6-phosphatase-related protein, the beta cell antigenic sequence that is targeted in diabetes is not responsible for the loss of phosphohydrolase activity.

Authors:  J-J Shieh; C-J Pan; B C Mansfield; J Y Chou
Journal:  Diabetologia       Date:  2005-07-13       Impact factor: 10.122

6.  Endotoxin-induced alterations in hepatic glucose-6-phosphatase activity and gene expression.

Authors:  S R Maitra; M L Gestring; M R El-Maghrabi; C H Lang; M C Henry
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

7.  Differential time course of liver and kidney glucose-6 phosphatase activity during long-term fasting in rat correlates with differential time course of messenger RNA level.

Authors:  C Minassian; C Zitoun; G Mithieux
Journal:  Mol Cell Biochem       Date:  1996-02-09       Impact factor: 3.396

8.  Effect of gastric bypass combined with ileal transportation on type 2 diabetes mellitus.

Authors:  Zhaoxia Gao; Bin Wang; Xiaojun Gong; Chun Yao; Defa Ren; Liwei Shao; Yan Pang; Jinxiu Liu
Journal:  Exp Ther Med       Date:  2018-03-06       Impact factor: 2.447

9.  Hepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription.

Authors:  R S Streeper; E M Eaton; D H Ebert; S C Chapman; C A Svitek; R M O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes.

Authors:  Varman T Samuel; Sara A Beddow; Takanori Iwasaki; Xian-Man Zhang; Xin Chu; Christopher D Still; Glenn S Gerhard; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.